VSBC — Vitaspring Biomedical Co. Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
Annual balance sheet for Vitaspring Biomedical Co., fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2018 January 31st | 2019 January 31st | 2020 January 31st | 2021 January 31st | 2022 January 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.005 | 0 | 0 | 0.045 | 0.107 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | — | — | 2.95 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.011 | 0.01 | 0 | 0.189 | 3.06 |
| Net Property, Plant And Equipment | 0.002 | 0.001 | 0 | — | 0.525 |
| Other Long Term Assets | |||||
| Total Assets | 0.013 | 0.011 | 0 | 0.189 | 3.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.016 | 0.018 | 0 | 0.093 | 1.56 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.016 | 0.018 | 0 | 0.093 | 2.03 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.003 | -0.007 | 0 | 0.096 | 1.58 |
| Total Liabilities & Shareholders' Equity | 0.013 | 0.011 | 0 | 0.189 | 3.6 |
| Total Common Shares Outstanding |